Impact of circulating microRNA test (miRNA-371a-3p) on appropriateness of treatment and cost outcomes in patients with Stage I non-seminomatous germ cell tumours.
BJU Int
; 128(1): 57-64, 2021 07.
Article
in En
| MEDLINE
| ID: mdl-33124175
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Testicular Neoplasms
/
Neoplasms, Germ Cell and Embryonal
/
MicroRNAs
/
Circulating MicroRNA
Type of study:
Health_economic_evaluation
/
Observational_studies
/
Prognostic_studies
Limits:
Humans
/
Male
Language:
En
Journal:
BJU Int
Journal subject:
UROLOGIA
Year:
2021
Type:
Article
Affiliation country:
United States